Experienced in Twin-To-Twin Transfusion Syndrome

Elad Dan-Mei

2075, Bayview Ave, 
Toronto, ON, CA 
Experienced in Twin-To-Twin Transfusion Syndrome
2075, Bayview Ave, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Elad Dan-Mei practices in Toronto, Canada. Mr. Dan-Mei is rated as an Experienced expert by MediFind in the treatment of Twin-To-Twin Transfusion Syndrome. His top areas of expertise are Intrauterine Growth Restriction, Preeclampsia, Choroid Plexus Cyst, and Infant Respiratory Distress Syndrome.

His clinical research consists of co-authoring 61 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Twin-To-Twin Transfusion Syndrome.

Gender
Male

Locations

2075, Bayview Ave, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada
Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada
Enrollment Status: Completed
Publish Date: April 25, 2025
Intervention Type: Other
Inpatient vs Outpatient Management of Women With Short Cervix: A Randomized Controlled Trial (RCT)
Inpatient vs Outpatient Management of Women With Short Cervix: A Randomized Controlled Trial (RCT)
Enrollment Status: Terminated
Publish Date: April 22, 2024
Intervention Type: Other
Study Phase: Not Applicable
Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial
Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial
Enrollment Status: Completed
Publish Date: August 23, 2021
Intervention Type: Drug
Study Drug: Progesterone
Study Phase: Phase 2
View 2 Less Clinical Trials

61 Total Publications

Technical Update No. 462: Abnormal maternal serum markers and adverse pregnancy outcomes.
Technical Update No. 462: Abnormal maternal serum markers and adverse pregnancy outcomes.
Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
Published: July 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dan-Mei's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile